EP1991201
Úðunarsýklalyf til innöndunarlækninga
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.2.2007EP published:
28.3.2018EP application number:
07703355.3
EP translation filed:
24.5.2018Grant published:
15.6.2018EPO information:
European Patent Register
Max expiry date:
7.2.2027Expiry date:
7.2.2027
Title:
NEBULISED ANTIBIOTICS FOR INHALATION THERAPY
Timeline
Today
8.2.2007EP application
28.3.2018EP Publication
24.5.2018Translation submitted
15.6.2018Registration published
7.2.2027Expires
Owner
Name:
PARI Pharma GmbHAddress:
Moosstrasse 3, 82319, Starnberg, DE
Inventor
Name:
KELLER, ManfredAddress:
München, DE
Name:
AKKAR, AslihanAddress:
München, DE
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
06002734Date:
10.2.2006Country:
EP
Classification
Categories:
A61K 9/12, A61K 9/72, A61K 31/535, A61K 31/496, A61K 31/4709
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 18.1.2019
Expires: 7.2.2020
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 20.1.2020
Expires: 7.2.2021
Payer: Sigurjónsson & Thor ehf.
Number: 15
Paid: 19.1.2021
Expires: 7.2.2022
Payer: Sigurjónsson & Thor ehf.
Number: 16
Paid: 18.1.2022
Expires: 7.2.2023
Payer: Patice ehf.
Number: 17
Paid: 19.1.2023
Expires: 7.2.2024
Payer: Árnason Faktor ehf.
Number: 18
Paid: 7.2.2024
Expires: 7.2.2025
Payer: Maxval Group, Inc.
Number: 19
Paid: 24.1.2025
Expires: 7.2.2026
Payer: Árnason Faktor ehf.
Number: 20
Paid: 13.2.2026
Expires: 7.2.2027
Payer: Árnason Faktor ehf.